USP Drug Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level 

 Analgesics
 
 Anesthetics
 
 Anti-Addiction/Substance Abuse Treatment Agents
 
 Antibacterials
 
 Anticonvulsants
 
 Antidementia Agents
 
 Antidepressants
 
 Antiemetics
 
 Antifungals
 
 Antigout Agents
 
 Anti-inflammatory Agents
 
 Antimigraine Agents
 
 Antimyasthenic Agents
 
 Antimycobacterials
 
 Antineoplastics
 
 Antiparasitics
 
 Antiparkinson Agents
 
 Antipsychotics
 
 Antispasticity Agents
 
 Antivirals
 
 Anxiolytics
 
 Bipolar Agents
 
 Blood Glucose Regulators
 
 Blood Products/Modifiers/Volume Expanders
 
 Cardiovascular Agents
 
 Central Nervous System Agents
 
 Dental and Oral Agents
 
 Dermatological Agents
 
 Electrolytes/Minerals/Metals/Vitamins
 
 Gastrointestinal Agents
 
 Genetic or Enzyme Disorder: Replacement, Modifiers, Treatment
 
 Genitourinary Agents
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
 
 Hormonal Agents, Suppressant (Adrenal)
 
 Hormonal Agents, Suppressant (Pituitary)
 
 Hormonal Agents, Suppressant (Thyroid)
 
 Immunological Agents
 
 Inflammatory Bowel Disease Agents
 
 Metabolic Bone Disease Agents
 
 Ophthalmic Agents
 
 Otic Agents
 
 Respiratory Tract/Pulmonary Agents
   Antihistamines
   Anti-inflammatories, Inhaled Corticosteroids
   Antileukotrienes
   Bronchodilators, Anticholinergic
   Bronchodilators, Sympathomimetic
     Albuterol
     Arformoterol [DG:DG01233]
     Ephedrine [DG:DG00227]
     Epinephrine [DG:DG00013]
       D00095  Epinephrine (USP/INN)
       D00996  Epinephrine hydrochloride (JAN)
       D02149  Epinephrine bitartrate (JAN/USP)
     Formoterol [DG:DG01052]
     Indacaterol [DG:DG01057]
     Levalbuterol [DG:DG01235]
     Metaproterenol
     Salmeterol [DG:DG01051]
     Terbutaline [DG:DG01046]
     Olodaterol [DG:DG01058]
   Cystic Fibrosis Agents
   Mast Cell Stabilizers
   Phosphodiesterase Inhibitors, Airways Disease
   Pulmonary Antihypertensives
   Respiratory Tract Agents, Other
   Pulmonary Fibrosis Agents
 
 Skeletal Muscle Relaxants
 
 Sleep Disorder Agents

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 12, 2017
According to the USP Medicare Model Guidelines v7.0

» Japanese version